Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma
Keisuke Nakao(Central Research Institute of Electric Power Industry), Minoru Tanabe(Tokyo Institute of Technology), Yusuke Mitsunori(Tokyo Medical and Dental University), Tomoya Miura(Tokyo Medical and Dental University), Shinji Tanaka(Tokyo Institute of Technology), Arihiro Aihara(Tokyo Medical and Dental University), Satoshi Matsumura(Saitama University), Atsushi Kudo(Tokyo Medical and Dental University), Takanori Ochiai(Tokyo Medical and Dental University), Daisuke Ban(Tokyo Medical and Dental University), Shigeki Arii(Kyoto University), Kota Sato(Fukuyama Cardiovascular Hospital)
Cited by 10
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
A novel difficulty scoring system for laparoscopic liver resection
|Journal of Hepato-Biliary-Pancreatic Sciences|2014|560
In-Orbit Performance of the Hard X-Ray Detector on Board Suzaku
|Publications of the Astronomical Society of Japan|2007|334
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267